20131 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials Compounds of unknown constitution, e.g. material from plants or animals
Protein Based Soft Chew Tablets
#2TICAGRELOR SOLID DISPERSION, METHOD FOR PREPARING SAME, AND USE THEREOF
#3NEW COATING SYSTEM (I)
#4Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#5SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING COMPLEX MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF MEDICAMENTS IN THE GASTROINTESTINAL TRACT
#6COMPRESSED TABLETS
#7Compositions comprising a cannabinoid and uses thereof
#8PROTECTIVE COATING FOR MOISTURE SENSITIVE PHARMACEUTICAL COMPOSITIONS
#9TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTIBODIES AND FRAGMENTS THEREOF
#10COMPOSITION FOR COATING TABLET
#11NOVEL EXTENDED RELEASE COMPOSITION OF 2-(2- AMINOTHIAZOL-4-YL)-N-[4-(2{[(2R)-2-HYDROXY-2-PHENYLETHYL] AMINO} ETHYL) PHENYL] ACETAMIDE
#12TABLETS HAVING DISCONTINUOUS COATED REGIONS
#13OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES
#14TABLETS HAVING DISCONTINUOUS COATED REGIONS
#15DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#16CONTROLLED RELEASE SOLID DOSE FORMS
#17Tablet dosage formulations of oleyl phosphocholine
#18Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
#19SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING COMPLEX MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF MEDICAMENTS IN THE GASTROINTESTINAL TRACT
#20Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#21DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#22Enterically coated cysteamine, cystamine and derivatives thereof
#23Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#24Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
#25Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#26Delayed release drug formulation
#27Topical treatment of inflammatory bowel disease using antibodies and fragments thereof
#28Tablets having discontinuous coated regions
#29Compressed tablets
#30ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#31ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES
#32DELAYED-RELEASE FORMULATIONS, METHODS OF MAKING AND USE THEREOF
#33COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#34SLOW RELEASE COMPOSITION OF ACTIVE INGREDIENTS
#35CONTROLLED RELEASE SOLID DOSE FORMS
#36Immediate release pharmaceutical composition of iron chelating agents
#37Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2
#38Compositions and methods for controlling carbohydrate and fat metabolism
#39Enterically coated cysteamine, cystamine and derivatives thereof
#40Carvedilol Immediate Release Formulation Having Improved Madescent
#41Tablets having discontinuous coated regions
#42Pharmaceutical bead formulations comprising dimethyl fumarate
#43Modified-release therapeutic systems for oral administration of curcumin in the treatment of intestinal disorders
#44Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders
#45Pharmaceutical processing
#46Press coated tablet prepared for delayed release of an active ingredient
#47Enterically coated cysteamine, cystamine and derivatives thereof
#48Enterically coated cysteamine, cystamine and derivatives thereof
#49Enterically coated cysteamine, cystamine and derivatives thereof
#50Delayed release drug formulation
#51THREE-PHASE CONTROLLED-RELEASE TABLET COMPRISING MELATONIN AND PROCESS OF PREPARATION
#52Pharmaceutical compositions resistant to abuse
#53Enterically coated cysteamine, cystamine and derivatives thereof
#54Delayed release drug formulation
#55Compositions and methods for controlling carbohydrate and fat metabolism
#56Enterically coated cysteamine, cystamine and derivatives thereof
#57Enterically coated cysteamine, cystamine and derivatives thereof
#58Coated solid dosage forms
#59Slow-release solid oral compositions
#60Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#61APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM
#62Composition for the oral administration of magnesium, in association with a composition for treating type 2 diabetes or the complications thereof
#63Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism
#64COMPOSITIONS AND METHODS FOR CANNABINOID COATINGS FOR USE IN DRUG DELIVERY
#65Coating composition based on coloring foodstuffs
#66Method for preparing pharmaceutical compositions of rhizomes from or having a high content of 1′S-1′-acetoxychavicol acetate (ACA)
#67Delayed-release formulations, methods of making and use thereof
#68ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS
#69Stable pharmaceutical compositions of saxagliptin or salts thereof
#70Artemisinin with berberine compositions and methods of making
#71Delayed release drug formulation
#72Delayed release drug formulation
#73Pharmaceutical preparation and method for treatment of diabetes
#74DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE
#75Coated solid dosage forms
#76Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
#77Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#78Machine for the manufacture of dosage forms utilizing radiofrequency energy
#79Formulation for providing an enteric coating material
#80Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#81Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#82Shellac-coated particles of active ingredients with controlled release properties at high pH-values, process for their manufacture and use thereof
#83METHOD OF ADDING BOTANICAL AGENTS/DIETARY SUPPLEMENTS TO PHARMACEUTICAL AGENTS IN A PHARMACOTHERAPEUTIC REGIMEN
#84NATURAL COATING FORMULAS AND COMPOSITION FOR COATING TABLETS
#85Delayed release drug formulation
#86Manufacture of lozenge product with radiofrequency
#87Artemisinin with berberine compositions and methods of making
#88Pulsatile drug release
#89Controlled Release Solid Dose Forms
#90ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF
#91PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE
#92Coated solid dosage forms
#93MANUFACTURE OF TABLET IN A DIE UTILIZING POWDER BLEND CONTAINING WATER-CONTAINING MATERIAL
#94Enterically coated cysteamine, cystamine and derivatives thereof
#95METHOD OF ADDING BOTANICAL AGENTS/DIETARY SUPPLEMENTS TO PHARMACEUTICAL AGENTS IN A PHARMACOTHERAPEUTIC REGIMEN
#96APPETISING MEDICAMENTS FOR ORAL ADMINISTRATION IN SOLID FORM FOR PREVENTION AND/OR TREATMENT OF CARDIAC INSUFFICIENCY IN ANIMALS
#97APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM
#98Herbal pain killer compositions
#99Manufacture of tablet in a die utilizing powder blend containing water-containing material
#100Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
#101Manufacture of lozenge product with radiofrequency
#102ORALLY TRANSFORMABLE TABLETS
#103Manufacture of chewing gum product with radiofrequency
#104Machine for the manufacture of dosage forms utilizing radiofrequency energy
#105Film coating composition from solid powder hydrophobic compounds
#106METHOD AND ARRANGEMENT FOR FORMING VARIABLE COLOR PHARMACEUTICAL PRODUCTS
#107Pharmaceutical compositions resistant to abuse
#108DELAYED-RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID ARTHRITIS BY IMPROVING SIGNS AND SYMPTOMS, SHOWING MAJOR OR COMPLETE CLINICAL RESPONSE AND BY PREVENTING FROM JOINT DAMAGE
#109PHARMACEUTICAL ARTICLES COATED WITH LUBRICIOUS COATINGS
#110PROCESS FOR PRODUCTION OF TABLET
#111HIGH GLOSS NON-STICK FILM COATING COMPOSITIONS
#112NATURAL DIETARY SUPPLEMENT TABLET
#113NATURAL PRODUCT COATING FOR TABLETS
#114Enterically coated cystamine, cysteamine and derivatives thereof
#115SIROLIMUS HAVING SPECIFIC PARTICLE SIZE AND PHARMACEUTICAL COMPOSITIONS THEREOF
#116Buffered coated nicotine containing products
#117Structurally Layered Composition for Daily Diet
#118PHARMACEUTICAL COMPOSITION COMPRISING STABILIZED STATIN PARTICLES
#119Formulation for providing an enteric coating material
#120Fiber rich fraction of seeds and its use as a pharmaceutical excipient
#121Tables delivery system